Armata Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Armata Pharmaceuticals, Inc. (NYSE American: ARMP) on April 2, 2026. The filing announces the scheduling of the Company's 2026 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing.
Guidance, Outlook, and Other Events
- Annual Meeting Date: June 11, 2026.
- Time and Location: 8:30 a.m. (Pacific Time) at 5005 McConnell Avenue, Los Angeles, California 90066, unless otherwise determined by the Board.
- Record Date: Stockholders of record as of the close of business on April 17, 2026, are entitled to notice and vote.
- Proposal Deadline: The deadline for stockholder proposals and director nominations under the Advance Notice Bylaws is 5:00 p.m. (Pacific Time) on April 12, 2026.
Key Facts for Investor Verification
- Verify the record date of April 17, 2026, to confirm voting eligibility.
- Confirm the April 12, 2026, deadline if intending to submit stockholder proposals or director nominations.
- Monitor the upcoming proxy statement for any changes to the meeting time or location.